WallachBeth Capital Announces Closing of bioAffinity Technologies $3.25m Offering

Core Viewpoint - bioAffinity Technologies, Inc. has successfully closed a best efforts offering of securities, raising a total of $3.25 million before expenses [1]. Group 1: Offering Details - The offering included 10,156,250 shares of Common Stock and warrants to purchase up to 15,234,375 shares of Common Stock, with a combined public offering price of $0.32 per share or pre-funded warrant [2]. - WallachBeth Capital, LLC served as the sole placement agent for this offering [2]. Group 2: Company Background - WallachBeth Capital LLC provides a wide range of capital markets and investment banking services, particularly to the healthcare sector, facilitating connections between corporate clients and leading institutions [5].